Liquidia (LQDA) Net Shares Issued and Repurchased (2020 - 2026)
Liquidia (LQDA) posted Net Shares Issued and Repurchased of $32548.0 for Q1 2026, down 75.32% on a QoQ basis from $131867.0 in Q4 2025.
Analysis
Liquidia (LQDA) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
Liquidia has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $32548.0 in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $32548.0 in Q1 2026; TTM through Mar 2026 was $32548.0, a N/A change from a year earlier, with the FY2025 full-year figure at $131867.0, down 31.44% from the prior year.
- Net Shares Issued and Repurchased was $32548.0 for Q1 2026 at Liquidia, down from $131867.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $4.5 million in Q4 2022, with the low at $7500.0 in Q1 2024.
- Average Net Shares Issued and Repurchased over 5 years is $1.2 million, with a median of $668241.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased jumped 121.81% in 2022, then slumped 99.34% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $4.5 million in 2022, then sank by 67.39% to $1.5 million in 2023, then plunged by 86.86% to $192336.0 in 2024, then sank by 31.44% to $131867.0 in 2025, then slumped by 75.32% to $32548.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $32548.0 (Q1 2026), $131867.0 (Q4 2025), and $192336.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Liquidia | 6.14 Bn | 5.86 Bn | 160.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 32,548.00 |
| Dec 31, 2025 | 131,867.00 |
| Dec 31, 2024 | 192,336.00 |
| Mar 31, 2024 | 7,500.00 |
| Dec 31, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 4.49 Mn |
| Mar 31, 2022 | 2.46 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 2.00 Mn |